| 000 | 01363 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514185359.0 | ||
| 264 | 0 | _c20040601 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0950-9232 | ||
| 024 | 7 |
_a10.1038/sj.onc.1207466 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCheng, Haiyun Y | |
| 245 | 0 | 0 |
_aArsenic inhibition of the JAK-STAT pathway. _h[electronic resource] |
| 260 |
_bOncogene _cApr 2004 |
||
| 300 |
_a3603-12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aArsenites _xpharmacology |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aEnzyme Activation _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aJanus Kinase 1 |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinases _xmetabolism |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSTAT3 Transcription Factor |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTrans-Activators _xantagonists & inhibitors |
| 700 | 1 | _aLi, Ping | |
| 700 | 1 | _aDavid, Michael | |
| 700 | 1 | _aSmithgall, Thomas E | |
| 700 | 1 | _aFeng, Lili | |
| 700 | 1 | _aLieberman, Michael W | |
| 773 | 0 |
_tOncogene _gvol. 23 _gno. 20 _gp. 3603-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.onc.1207466 _zAvailable from publisher's website |
| 999 |
_c14826727 _d14826727 |
||